Healthcare

The future value of contingent value rights (CVRs) issued following AbbVie's acquisition of Landos Biopharma hinges on a single, upcoming...

Investor sentiment toward Anavex Life Sciences has brightened following the release of new clinical data for its lead Alzheimer's disease...

Biotechnology firm Ocugen has completed patient enrollment for the pivotal Phase 3 clinical trial of its lead candidate, OCU400, a...

Danaher Corporation has outlined a definitive strategic roadmap targeting the 2026 fiscal year. While acknowledging specific regional headwinds, the company's...

Intuitive Surgical, a leader in robotic-assisted surgery, is strategically refining its operational footprint to navigate a shifting competitive landscape. The...

The healthcare giant Johnson & Johnson is pursuing a dual strategy to enhance patient access and advance its pipeline. In...

A significant legal case commenced in Chicago on March 4, targeting global healthcare company Abbott Laboratories. The core of the...

With a notable absence of recent company-specific announcements, Animalcare's stock is currently trading in a quiet phase. This lack of...

Biopharmaceutical firm Ocugen has achieved a significant clinical development goal just two days before its annual financial report. Company leadership...

For the first time in ten years, UnitedHealth Group is forecasting a drop in revenue, marking a significant inflection point...